The National Company Law Tribunal (NCLT) has approved a significant corporate restructuring initiative by Fortis Healthcare , allowing the merger of the company's wholly owned subsidiaries with Fortis Hospitals Limited.

Merger Details and Timeline

The approved merger arrangement involves the consolidation of Fortis Healthcare's wholly owned subsidiaries into Fortis Hospitals Limited. The NCLT's approval marks a crucial milestone in the company's organizational restructuring efforts.

Regulatory Compliance

While the NCLT has granted its approval for the merger, the implementation remains contingent upon completing the necessary registrations with the Registrar of Companies (ROC). This regulatory step is essential for the legal formalization of the merger process.

Corporate Restructuring Impact

The merger represents a strategic consolidation move that will bring Fortis Healthcare's wholly owned subsidiaries under the umbrella of Fortis Hospitals Limited. This organizational restructuring is designed to streamline operations and create a more unified corporate structure within the healthcare group.

The NCLT's approval provides the legal framework necessary for Fortis Healthcare to proceed with its planned subsidiary consolidation, subject to fulfilling the remaining regulatory requirements with the ROC.

Fortis Healthcare Limited , a leading player in the Indian healthcare sector, has received final approval from the National Company Law Tribunals (NCLTs) for its composite scheme of merger by absorption involving multiple wholly-owned subsidiaries.

NCLT Approval Timeline

The company has secured approvals from both jurisdictional NCLTs for the restructuring scheme:

Entities Involved in the Merger

The scheme involves the merger of four wholly-owned subsidiaries into Fortis Hospitals Limited (FHsL):

Financial Details of Subsidiaries

The financial profile of the entities involved in the merger shows varying scales of operations:

Strategic Rationale and Implementation

The merger aims to achieve operational rationalization and cost optimization through simplified management structures and streamlined financial reporting. The scheme will become effective once certified copies of both NCLT orders are filed with the jurisdictional Registrar of Companies.

Since all transferor companies are wholly-owned subsidiaries of FHsL, the merger will not involve any share issuance or cash consideration. The shareholding pattern of Fortis Healthcare Limited, the listed entity, will remain unchanged following this internal restructuring.

Regulatory Compliance

The transaction falls under related party arrangements but is exempt from Section 188 requirements of the Companies Act, 2013, as per MCA General Circular No. 30/2014. Additionally, related party transaction provisions under SEBI LODR Regulations do not apply to this scheme under Regulation 23(5)(c).